| Praxis Precision Medicines, Inc. | 2.02M | US$590M | 10.3% |
| Amylyx Pharmaceuticals, Inc. | 10.6M | US$308M | 5.4% |
| Spyre Therapeutics, Inc. | 3.28M | US$292M | 5.1% |
| Celcuity Inc. | 3.18M | US$253M | 4.4% |
| Rhythm Pharmaceuticals, Inc. | 2.53M | US$241M | 4.2% |
| Roivant Sciences Ltd. | 6.51M | US$238M | 4.1% |
| Relay Therapeutics, Inc. | 12.7M | US$230M | 4.0% |
| Travere Therapeutics, Inc. | 3.54M | US$209M | 3.6% |
| Freenome, Inc. | 12.6M | US$199M | 3.5% |
| Edgewise Therapeutics, Inc. | 4.14M | US$168M | 2.9% |
| Inhibrx Biosciences, Inc. | 1.29M | US$129M | 2.3% |
| Nurix Therapeutics, Inc. | 5.37M | US$127M | 2.2% |
| Kardigan, Inc. | 8.2M | US$121M | 2.1% |
| MeiraGTx Holdings plc | 10.8M | US$119M | 2.1% |
| Protagonist Therapeutics, Inc. | 837K | US$118M | 2.1% |
| Zymeworks Inc. | 3.55M | US$93.9M | 1.6% |
| Oruka Therapeutics, Inc. | 1.07M | US$89.3M | 1.6% |
| Revolution Medicines, Inc. | 433K | US$88.9M | 1.5% |
| Solid Biosciences Inc. | 11.9M | US$86.1M | 1.5% |
| BioCryst Pharmaceuticals, Inc. | 10.3M | US$85.8M | 1.5% |
| Avalyn Pharma Inc. | 2.68M | US$76.2M | 1.3% |
| Tango Therapeutics, Inc. | 2.69M | US$67.2M | 1.2% |
| Waters Corporation | 135K | US$59.3M | 1.0% |
| Repligen Corporation | 272K | US$52.4M | 0.91% |
| Artivion, Inc. | 2.11M | US$48.2M | 0.84% |
| Alto Neuroscience, Inc. | 1.76M | US$45M | 0.78% |
| Opus Genetics, Inc. | 9M | US$43.6M | 0.76% |
| Lakefront Biotherapeutics | 1.24M | US$36.8M | 0.64% |
| Abbott Laboratories | 345K | US$34.1M | 0.59% |
| BlossomHill Therapeutics, Inc. | 1.81M | US$33.8M | 0.59% |
| Orchestra BioMed Holdings, Inc. | 5.04M | US$31.3M | 0.55% |
| Corvus Pharmaceuticals, Inc. | 2.51M | US$28.9M | 0.50% |
| Anteris Technologies Global Corp. | 3.43M | US$26.6M | 0.46% |
| Adlai Nortye Group Ltd. | 1.66M | US$26.6M | 0.46% |
| MiniMed Group, Inc. | 1.32M | US$25.7M | 0.45% |
| CytomX Therapeutics, Inc. | 9.27M | US$25.2M | 0.44% |
| Rapport Therapeutics, Inc. | 724K | US$24.3M | 0.42% |
| Septerna, Inc. | 567K | US$22.2M | 0.39% |
| X4 Pharmaceuticals, Inc. | 7.35M | US$21.3M | 0.37% |
| Enliven Therapeutics, Inc. | 463K | US$21.2M | 0.37% |
| SAB Biotherapeutics, Inc. | 6.63M | US$21M | 0.37% |
| Dyne Therapeutics, Inc. | 1.27M | US$20.4M | 0.36% |
| Evolus, Inc. Common Stock | 2.46M | US$19.7M | 0.34% |
| Immunovant, Inc. | 519K | US$17.5M | 0.31% |
| Scribe Therapeutics Inc. | 920K | US$16.9M | 0.30% |
| Nautilus Biotechnology, Inc. | 11.6M | US$16.4M | 0.29% |
| Sutro Biopharma, Inc. | 971K | US$15.6M | 0.27% |
| Surrozen, Inc. | 440K | US$14.1M | 0.25% |
| GRAIL, Inc. | 96,911 | US$13.6M | 0.24% |
| DBV Technologies SA | 1.14M | US$13.4M | 0.23% |
| Danaher Corporation | 60,000 | US$13.3M | 0.23% |
| iRhythm Holdings, Inc. | 114K | US$12.9M | 0.23% |
| Guardant Health, Inc. | 70,000 | US$12.5M | 0.22% |
| Invivyd, Inc. | 13.8M | US$12M | 0.21% |
| Adaptive Biotechnologies Corporation | 412K | US$11.9M | 0.21% |
| Veradermics, Incorporated | 97,000 | US$11.8M | 0.20% |
| Axogen, Inc. | 280K | US$11.7M | 0.20% |
| Palisade Bio, Inc. | 8.43M | US$11.4M | 0.20% |
| Crescent Biopharma, Inc. | 707K | US$10.3M | 0.18% |
| Beta Bionics, Inc. | 538K | US$10.2M | 0.18% |
| Seaport Therapeutics, Inc. | 500K | US$10.1M | 0.18% |
| Mirum Pharmaceuticals, Inc. | 115K | US$9.86M | 0.17% |
| Xeris Biopharma Holdings, Inc. | 934K | US$8.93M | 0.16% |
| Research Alliance Corporation IV | 700K | US$8.29M | 0.14% |
| Capricor Therapeutics, Inc. | 850K | US$8.05M | 0.14% |
| Viridian Therapeutics, Inc. | 381K | US$7.85M | 0.14% |
| Abivax SA | 74,000 | US$7.33M | 0.13% |
| BillionToOne, Inc. | 65,209 | US$6.94M | 0.12% |
| AgomAb Therapeutics NV | 600K | US$6.66M | 0.12% |
| LeonaBio, Inc. | 1.86M | US$6.64M | 0.12% |
| Biogen Inc. | 28,030 | US$6.33M | 0.11% |
| ADARx Pharmaceuticals, Inc. | 300K | US$5.98M | 0.10% |
| Nuvectis Pharma, Inc. | 240K | US$5.07M | 0.09% |
| Olema Pharmaceuticals, Inc. | 575K | US$4.97M | 0.09% |
| UnitedHealth Group Incorporated | 10,000 | US$3.67M | 0.06% |
| Mobia Medical, Inc. | 344K | US$3.25M | 0.06% |
| Outset Medical, Inc. | 833K | US$2.5M | 0.04% |
| CeriBell, Inc. | 98,779 | US$2.41M | 0.04% |
| Edesa Biotech, Inc. | 563K | US$2.37M | 0.04% |
| Braveheart Bio, Inc. | 115K | US$2.32M | 0.04% |
| Outlook Therapeutics, Inc. | 3.14M | US$1.8M | 0.03% |
| Adagio Medical Holdings, Inc | 9.88M | US$1.51M | 0.03% |
| ADMA Biologics Inc | 114K | US$1.14M | 0.02% |
| Kiora Pharmaceuticals, Inc. | 438K | US$1.12M | 0.02% |
| Medline Inc. | 28,000 | US$972K | 0.02% |
| Exagen Inc. | 115K | US$934K | 0.02% |
| Connect Biopharma Holdings Limited | 793K | US$872K | 0.02% |
| Sagimet Biosciences Inc. - Series A | 67,674 | US$669K | 0.01% |
| iShares Bitcoin Trust ETF | 12,000 | US$568K | <0.01% |
| Ensysce Biosciences, Inc. | 86,666 | US$36,036 | <0.01% |
| Research Alliance Corporation III | 0 | US$0 | 0.00% |
| Sionna Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Tenax Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Twist Bioscience Corporation | 0 | US$0 | 0.00% |
| Apogee Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Avalo Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Axsome Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Biodesix, Inc. | 0 | US$0 | 0.00% |
| Boston Scientific Corporation | 0 | US$0 | 0.00% |
| Charles River Laboratories International, Inc. | 0 | US$0 | 0.00% |